TAUNS Laboratories, Inc.
197A.T · JPX
6/30/2025 | 6/30/2024 | 6/30/2023 | 6/30/2022 | |
|---|---|---|---|---|
| Market Cap | ¥54,736,464 | ¥44,597,034 | ¥41,900,000 | ¥41,900,000 |
| - Cash | ¥9,266,630 | ¥9,424,891 | ¥1,244,375 | ¥6,347,420 |
| + Debt | ¥14,424,000 | ¥9,539,000 | ¥6,468,000 | ¥4,900,000 |
| Enterprise Value | ¥59,893,834 | ¥44,711,143 | ¥47,123,625 | ¥40,452,580 |
| Revenue | ¥18,627,990 | ¥18,434,863 | ¥15,673,099 | ¥17,456,987 |
| % Growth | 1% | 17.6% | -10.2% | – |
| Gross Profit | ¥12,325,792 | ¥12,498,333 | ¥8,786,449 | ¥14,287,440 |
| % Margin | 66.2% | 67.8% | 56.1% | 81.8% |
| EBITDA | ¥9,020,205 | ¥8,646,446 | ¥5,316,638 | ¥8,551,292 |
| % Margin | 48.4% | 46.9% | 33.9% | 49% |
| Net Income | ¥6,315,407 | ¥5,774,086 | ¥3,034,863 | ¥4,480,753 |
| % Margin | 33.9% | 31.3% | 19.4% | 25.7% |
| EPS Diluted | 58.9 | 57.74 | 30.35 | 44.81 |
| % Growth | 2% | 90.2% | -32.3% | – |
| Operating Cash Flow | ¥6,818,472 | ¥9,935,074 | -¥3,157,606 | ¥10,694,688 |
| Capital Expenditures | -¥4,681,019 | -¥3,961,199 | -¥1,165,613 | -¥2,300,025 |
| Free Cash Flow | ¥2,137,453 | ¥5,973,875 | -¥4,323,219 | ¥8,394,663 |